Basal Cell Carcinoma: Understanding the Most Common Skin Cancer

Basal cell carcinoma is the most prevalent type of skin cancer affecting fair-skinned individuals. Characterized by slow growth and rare metastasis, surgical removal remains the gold standard for treating this condition. However, some patients are not suitable for surgery due to the high risk of disfigurement or multiple tumors. These individuals often have genetic disorders, such as Gorlin-Goltz syndrome, or have developed multiple basal cell carcinomas as a result of UV light-induced field cancerization.

For these patients, conservative treatment options have been developed in recent years. Topical therapies are effective for superficial basal cell carcinomas, while targeted systemic therapies are used for locally advanced and metastatic basal cell carcinomas. This book provides a comprehensive overview of the approved and emerging medicinal treatment options, taking into account the latest study results.

Basal Cell Carcinoma Treatment Options

• Surgical Removal: The gold standard for treating basal cell carcinoma, but not suitable for patients with multiple tumors or high risk of disfigurement.
• Topical Therapies: Effective for superficial basal cell carcinomas, offering a non-invasive treatment approach.
• Targeted Systemic Therapies: Used for locally advanced and metastatic basal cell carcinomas, providing a more targeted approach to treatment.

This book is an invaluable resource for patients and healthcare professionals seeking to understand the complex treatment landscape of basal cell carcinoma. With its comprehensive coverage of medicinal treatment options and latest study results, it provides a vital tool for making informed decisions about treatment.

Book Details:

Published by: UNI-MED Verlag AG

Second Edition: February 1, 2016

Language: German

ISBN-10: 3837423476

ISBN-13: 978-3837423471